Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Elizabeth Hanna

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Tuberculosis (Edinburgh, Scotland)|June 15, 2017
Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing eraAmeeruddin Nusrath Unissa, Luke Elizabeth Hanna
Virus Research|April 30, 2026
HIV ENVELOPE PSEUDOTYPED VIRUS- AN INDISPENSABLE TOOL IN HIV RESEARCHSandhya Vivekanandan, Aanand Sonawane, Luke Elizabeth Hanna
Frontiers in Medicine|December 5, 2022
Design of human immunodeficiency virus-1 neutralizing peptides targeting CD4-binding site: An integrative computational biologics approachSandhya Vivekanandan, Umashankar Vetrivel, Luke Elizabeth Hanna
Clinical Microbiology Reviews|November 15, 2023
Experimental models for HIV latency and molecular tools for reservoir quantification-an updateDivyadarshini Angamuthu, Sandhya Vivekanandan, Luke Elizabeth Hanna
Bioinformation|October 31, 2025
<i>In silico</i> analysis of hypo-upregulated genes as biomarkers in lung adenocarcinomaBinisha Robinson, Luke Elizabeth Hanna, Shanmughavel Piramanayagam
Chemical Biology & Drug Design|November 28, 2015
A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosisAmeeruddin Nusrath Unissa, Luke Elizabeth Hanna, Soumya Swaminathan
Tuberculosis and Respiratory Diseases|July 28, 2017
The Role of <i>N</i>-Acetyl Transferases on Isoniazid Resistance from <i>Mycobacterium tuberculosis</i> and Human: An <i>In Silico</i> ApproachAmeeruddin Nusrath Unissa, Swathi Sukumar, Luke Elizabeth Hanna
Plos One|January 15, 2014
PknE, a serine/threonine protein kinase of Mycobacterium tuberculosis initiates survival crosstalk that also impacts HIV coinfectionDinesh Kumar Parandhaman, Luke Elizabeth Hanna, Sujatha Narayanan
Immunogenetics|July 20, 2012
Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccineJagadish Chandrabose Sundaramurthi, Soumya Swaminathan, Luke Elizabeth Hanna
Journal of Molecular Modeling|April 28, 2012
Computational structural analysis of proteins of Mycobacterium tuberculosis and a resource for identifying off-targetsSameer Hassan, Abhimita Debnath, Vasantha Mahalingam, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Tuberculosis (Edinburgh, Scotland)|June 15, 2017
Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing eraAmeeruddin Nusrath Unissa, Luke Elizabeth Hanna
Virus Research|April 30, 2026
HIV ENVELOPE PSEUDOTYPED VIRUS- AN INDISPENSABLE TOOL IN HIV RESEARCHSandhya Vivekanandan, Aanand Sonawane, Luke Elizabeth Hanna
Frontiers in Medicine|December 5, 2022
Design of human immunodeficiency virus-1 neutralizing peptides targeting CD4-binding site: An integrative computational biologics approachSandhya Vivekanandan, Umashankar Vetrivel, Luke Elizabeth Hanna
Clinical Microbiology Reviews|November 15, 2023
Experimental models for HIV latency and molecular tools for reservoir quantification-an updateDivyadarshini Angamuthu, Sandhya Vivekanandan, Luke Elizabeth Hanna
Bioinformation|October 31, 2025
<i>In silico</i> analysis of hypo-upregulated genes as biomarkers in lung adenocarcinomaBinisha Robinson, Luke Elizabeth Hanna, Shanmughavel Piramanayagam
Chemical Biology & Drug Design|November 28, 2015
A Note on Derivatives of Isoniazid, Rifampicin, and Pyrazinamide Showing Activity Against Resistant Mycobacterium tuberculosisAmeeruddin Nusrath Unissa, Luke Elizabeth Hanna, Soumya Swaminathan
Tuberculosis and Respiratory Diseases|July 28, 2017
The Role of <i>N</i>-Acetyl Transferases on Isoniazid Resistance from <i>Mycobacterium tuberculosis</i> and Human: An <i>In Silico</i> ApproachAmeeruddin Nusrath Unissa, Swathi Sukumar, Luke Elizabeth Hanna
Plos One|January 15, 2014
PknE, a serine/threonine protein kinase of Mycobacterium tuberculosis initiates survival crosstalk that also impacts HIV coinfectionDinesh Kumar Parandhaman, Luke Elizabeth Hanna, Sujatha Narayanan
Immunogenetics|July 20, 2012
Resistance-associated epitopes of HIV-1C-highly probable candidates for a multi-epitope vaccineJagadish Chandrabose Sundaramurthi, Soumya Swaminathan, Luke Elizabeth Hanna
Journal of Molecular Modeling|April 28, 2012
Computational structural analysis of proteins of Mycobacterium tuberculosis and a resource for identifying off-targetsSameer Hassan, Abhimita Debnath, Vasantha Mahalingam, et al.
Pageof 11